KOSPICosmetics003350

Hankook Cosmetics Manufacturing

₩11,020▲ 4.45%2026-11-18 close
Market Cap
₩249.7B
Turnover
₩3.9B
Volume
360K
Shares out.
22.7M
PER
6.3×
PBR
1.9×
EPS
₩1,836
Dividend Yield
—

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Prices as of the 2026-11-18 close

01

Report overview

A Cosmetics Maker Extending Its Profit Recovery

Revenue and operating profit have grown together since 2022, and quarterly revenue has risen for three straight quarters through the third quarter of 2026, although operating profit has moved unevenly from quarter to quarter.

  1. 1

    Annual revenue rose from KRW 103.9 billion in 2022 to KRW 184.6 billion in 2025, with 2025 operating profit at KRW 32.9 billion and net profit attributable to controlling shareholders at KRW 27.4 billion.

  2. 2

    The operating margin climbed from 4.2% in 2022 to 17.8% in 2025 as operating profit grew faster than revenue.

  3. 3

    Third-quarter 2026 revenue reached KRW 73.5 billion and operating profit KRW 13.2 billion; revenue rose from the prior quarter while operating profit fell 5.2%.

  4. 4

    The debt ratio rose from 47.2% in 2024 to 89.8% in 2025, indicating higher financial leverage.

  5. 5

    According to preliminary MFDS data, Korean cosmetics exports reached USD 11.1 billion in January–September 2026, up 31.1%, and the sector backdrop remains one of strong export growth.

02

Business structure

Hankook Cosmetics Manufacturing is a cosmetics manufacturer producing more than 700 types of basic and color cosmetics. Beyond producing products for the existing Hankook Cosmetics brand, the company also runs OEM and ODM business that manufactures products for outside cosmetics companies.

OEM means making products designed by the client, while ODM means the manufacturer also takes on product development, so order units and profit structures differ. Korea's cosmetics manufacturing market is clearly concentrated among a few leaders.

According to MFDS data for 2025, more than half of domestic ODM production records came from Cosmax and Kolmar Korea. Cosmecca Korea is ranked as the third-largest domestic ODM, while C&C International focuses on color cosmetics and Genic on hydrogel masks.

Customers are cosmetics brand companies, and industry participants say orders from indie brands are growing quickly. Under the Enforcement Rule of the Cosmetics Act, products must display the manufacturer's name, so consumers can identify the producer from the packaging.

Analysts say this trust factor is also why new brands look first to large ODM companies. The core of the business structure is basic and color production capacity together with a base of contract clients, and these two axes jointly shape revenue flows.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩54.8B₩11.9B21.6%
2025Q4₩38B₩4.2B11.1%
2026Q1₩52.2B₩8.6B16.4%
2026Q2₩71.2B₩14B19.6%
2026Q3₩73.5B₩13.2B18.0%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩103.9B₩4.3B₩4B4.2%8.5%75.0%
2023₩109.3B₩9B₩7.3B8.3%13.8%69.5%
2024₩167.5B₩26.5B₩23.1B15.9%31.2%47.2%
2025₩184.6B₩32.9B₩27.4B17.8%26.1%89.8%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-16

04

Earnings analysis

Annual revenue rose from KRW 103.9 billion in 2022 to KRW 109.3 billion in 2023 (up 5.3% year on year), KRW 167.5 billion in 2024 (up 53.2%), and KRW 184.6 billion in 2025 (up 10.2%). Revenue has increased for three consecutive years from 2023 through 2025, and 2025 was the largest year of the 2022–2025 period.

Profit grew faster than revenue. Operating profit went from KRW 4.32 billion in 2022 to KRW 9.02 billion in 2023 (up 109.0%), KRW 26.5 billion in 2024 (up 194.1%), and KRW 32.9 billion in 2025 (up 23.9%). As a result, the operating margin rose from 4.2% in 2022 to 8.3%, 15.9% and 17.8% in 2025.

In 2024, operating profit growth of 194.1% far exceeded revenue growth of 53.2%, making that year the most pronounced margin expansion.

Net profit attributable to controlling shareholders rose from KRW 4.03 billion in 2022 to KRW 27.4 billion in 2025, and net profit including non-controlling interests is disclosed with the same figures in each year.

Operating cash flow increased from KRW 6.31 billion in 2022 to KRW 36.3 billion in 2025, so profit growth also translated into cash generation. However, the debt ratio rose from 47.2% in 2024 to 89.8% in 2025, with total liabilities of KRW 94.1 billion and total equity of KRW 104.7 billion at year-end 2025.

On a quarterly basis, revenue of KRW 54.8 billion and operating profit of KRW 11.9 billion in the third quarter of 2025 gave way to a fourth-quarter 2025 low of KRW 38 billion in revenue (down 30.7% from the prior quarter) and KRW 4.21 billion in operating profit (down 64.5%).

Revenue then rose to KRW 52.2 billion in the first quarter of 2026 (up 37.4%), KRW 71.2 billion in the second (up 36.3%), and KRW 73.5 billion in the third (up 3.3%), increasing for three straight quarters.

Operating profit recovered to KRW 8.57 billion in the first quarter (up 103.9%) and KRW 14 billion in the second (up 62.7%), then eased to KRW 13.2 billion in the third quarter (down 5.2% from the prior quarter, up 11.6% year on year).

Net profit attributable to controlling shareholders was KRW 10.8 billion in the third quarter of 2026, unchanged from the second quarter, and the sum for the latest four quarters stands at KRW 33.3 billion.

In the third quarter of 2026, revenue rose while operating profit fell, so the quarterly margin came in below the prior quarter. The causes of the fourth-quarter 2025 decline and the third-quarter 2026 margin slowdown can be traced through the cost items in the regular reports.

05

Industry analysis

Korean cosmetics exports reached a record USD 11.4 billion in 2025. In the first half of 2026, exports rose 27.3% year on year to USD 7.0 billion, the largest half-year figure on record, according to MFDS.

The export base has also broadened: the United States was the largest market in the first half of 2026 at USD 1.45 billion, followed by China at USD 1.01 billion and Japan at USD 0.58 billion. Strong exports have fed through to ODM orders.

For January–September 2026, average monthly domestic output at Cosmax, Kolmar Korea and Cosmecca Korea was 86 million, 68.4 million and 44 million units respectively, totaling about 198.4 million units.

Cosmax's utilization is reported at 70–80%, the highest level on record, and Kolmar Korea's average utilization in the first half rose from 79.5% to 81.1%.

Capacity competition is intensifying, with Cosmax investing more than KRW 180 billion in expanding its Pyeongtaek plant and Cosmecca Korea planning KRW 200 billion in domestic plant investment through 2030.

Capacity additions take time to show results, and industry participants say the major ODM companies' year-end production schedules are already largely full.

Large, long-term clients are booked first, pushing small new orders toward mid-sized manufacturers, where production lead times have lengthened more than at the largest ODM companies. Demand for split production between Korea and the United States in response to US tariffs is also cited as an order driver.

In the third quarter of 2026, Cosmax, Kolmar Korea and Cosmecca Korea each posted record quarterly revenue, but operating profit growth varied: Cosmax rose 94.9%, while Cosmecca Korea was essentially flat, according to The Viewers. Hankook Cosmetics Manufacturing is smaller in revenue scale than these three leading ODM companies.

06

Outlook

Hankook Cosmetics Manufacturing's third-quarter 2026 revenue of KRW 73.5 billion rose 34.1% from KRW 54.8 billion in the third quarter of 2025, extending a run of quarterly increases.

Operating profit of KRW 13.2 billion in the third quarter of 2026 was up 11.6% year on year but below the KRW 14 billion recorded in the second quarter, so whether the profit trend holds will be tested in upcoming quarterly results.

Because revenue growth has translated into profit growth at different rates from quarter to quarter, production efficiency and client mix are the variables that will shape the next quarter's margin.

Across the sector, capacity additions are increasing while export momentum continues, so competition for capacity could become competition for orders. In an August 2026 report, analysts projected third-quarter domestic revenue growth of 35–40% at Cosmax.

In the same period, an analyst at Shinyoung Securities expected Kolmar Korea's major skincare clients to increase orders ahead of Black Friday in the fourth quarter.

Cosmecca Korea plans the first phase of its new Ochang plant in 2027, so capacity expansion among mid-sized ODM companies is expected to become more visible from that year. The 2026 annual report, the next regular filing, will show fourth-quarter revenue and the full-year operating margin.

07

Valuation

PER
6.3×
PBR
1.9×
ROE
28.4%
EPS
₩1,836
BPS
₩6,084
Dividend per share
—

The price-to-book ratio is above 1x, meaning the share price is trading at a premium to book value. All of the KRW 104.7 billion in total equity at year-end 2025 belongs to controlling shareholders, so changes in book value per share move with accumulated profits.

On the earnings side, net profit attributable to controlling shareholders was KRW 27.4 billion in 2025, up 18.3% from KRW 23.1 billion in 2024, and the sum for the latest four quarters is KRW 33.3 billion.

The price-to-earnings ratio should be read against the latest four quarters of earnings, a window that includes the fourth-quarter 2025 low, so quarterly swings affect how the multiple looks.

Over a longer span, operating profit grew from KRW 4.32 billion in 2022 to KRW 32.9 billion in 2025, a substantial expansion in earnings capacity. The debt ratio rising to 89.8% in 2025 is another variable to consider when interpreting the premium to book value.

Comparisons of multiples with listed ODM peers are meaningful only when both sides are measured over the same quarterly periods.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-16

08

Bull factors

Export tailwinds for the sector

Korean cosmetics exports reached a record USD 11.4 billion in 2025, and preliminary January–September 2026 exports of USD 11.1 billion were up 31.1%. Industry participants describe growing orders from indie brands, which supports an external environment that can expand order volume. Third-quarter 2026 revenue of KRW 73.5 billion, up 34.1% year on year, moves in the same direction.

Track record of margin expansion

The operating margin rose from 4.2% in 2022 to 17.8% in 2025, and operating profit grew from KRW 4.32 billion to KRW 32.9 billion over the same span. On a quarterly basis, operating profit rose 103.9% in the first quarter of 2026 and 62.7% in the second from the prior quarter, showing a recovery. The figures show revenue growth converting into profit.

Cash generation and recent earnings scale

Operating cash flow rose from KRW 6.31 billion in 2022 to KRW 36.3 billion in 2025. Net profit attributable to controlling shareholders for the latest four quarters totals KRW 33.3 billion. Profit translating into operating cash flow is one piece of evidence on earnings quality.

09

Bear factors

Volatility in quarterly profit

Revenue fell 30.7% from the prior quarter in the fourth quarter of 2025 and operating profit fell 64.5%, marking a low point. In the third quarter of 2026 revenue rose 3.3% while operating profit fell 5.2%. Quarterly profit has not moved in step with revenue, which is the starting point of the bear case.

Rising debt ratio

The debt ratio rose from 47.2% in 2024 to 89.8% in 2025. Total liabilities were KRW 94.1 billion and total equity KRW 104.7 billion at year-end 2025.

The reasons behind the increase in borrowing can be traced in the financial statement notes, and a change in rates or funding conditions could raise the weight of financing costs on profit.

Concentration among large players and rising competition

More than half of domestic ODM production records are concentrated in two companies, Cosmax and Kolmar Korea. As these two continue expanding capacity, competition for orders may intensify.

Production lead times at mid-sized ODM companies have lengthened more than at the largest players, showing that the competitive landscape among mid-sized makers is shifting quickly.

10

Risk factors

Trade and export environment

Demand for split production between Korea and the United States has emerged in response to US tariffs, but leading export markets are concentrated in the United States, China and Japan, so trade changes in any one country could affect order flows.

The United States being the top export market in the first half of 2026 also means sensitivity to trade policy shifts.

Quarterly earnings volatility

Profit recovered after the fourth-quarter 2025 low, but the quarterly margin in the third quarter of 2026 came in below the prior quarter. If costs and production efficiency do not keep pace with rising order volumes, operating profit may again lag revenue growth.

Financial leverage

A debt ratio of 89.8% is well above the 47.2% recorded in 2024. Because the industry is in a phase of continued capital investment, funding needs may rise. If debt burdens grow, financial flexibility could narrow when profits fluctuate, so the borrowing structure should be checked in the next regular report.

11

What to watch next

  1. Late January to early February 2027

    The MFDS annual cosmetics export tally for 2026 is expected, typically released early in the year. It will show whether the 31.1% growth in the preliminary January–September figures held for the full year.

  2. End of March 2027

    This is the deadline for the 2026 annual report. The causes of the fourth-quarter 2025 low and the third-quarter 2026 margin slowdown should appear in cost disclosures, and the full-year operating margin relative to 17.8% in 2025 will be visible.

  3. Mid-May 2027

    This is when the first-quarter 2027 quarterly report is due. It will show whether the revenue growth seen through the third quarter of 2026 continues, and whether operating profit returns to the KRW 14 billion level of the second quarter of 2026.

  4. First half of 2027

    The first phase of Cosmecca Korea's new Ochang plant and progress on Cosmax's Pyeongtaek expansion will be visible. The pace of domestic ODM capacity growth is an indicator of how intense order competition, including among mid-sized makers, becomes.

12

Overall view

Hankook Cosmetics Manufacturing has seen revenue and operating profit grow together since 2022, with the operating margin rising from 4.2% in 2022 to 17.8% in 2025. Net profit attributable to controlling shareholders reached KRW 27.4 billion in 2025, a substantially larger earnings base than in 2022.

However, both revenue and operating profit fell sharply in the fourth quarter of 2025, and in the third quarter of 2026 operating profit declined even as revenue rose, leaving the quarterly margin below the prior quarter. The debt ratio rose to 89.8% in 2025, indicating higher financial leverage.

The sector backdrop is supportive, with rising cosmetics exports and expanding ODM orders, but capacity competition and concentration among large ODM companies are structural variables.

Strength factors include export growth, margin improvement and higher cash generation, while weakness factors include quarterly profit volatility, a higher debt burden and intensifying competition.

The next checkpoints are the full-year operating margin in the 2026 annual report and quarterly results for the first quarter of 2027.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 15 more articles and sources
  1. investing.com
  2. markets.hankyung.com
  3. google.com
  4. accidentalorder.com
  5. m.finance.daum.net
  6. infostock.co.kr
  7. biz.heraldcorp.com
  8. fnnews.com
  9. m-i.kr
  10. hankyung.com
  11. m.news.nate.com
  12. bloter.net
  13. theviewers.co.kr
  14. m.news.nate.com
  15. m.news.nate.com

Report written 2026-11-16 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis